MegRebeccaGerstenblithMD

Assistant Professor, Dermatology, Case Western Reserve University School of Medicine

Dr. Gerstenblith is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins UniversityResidency, Dermatology, 2006 - 2009
University of Pennsylvania Health SystemInternship, Internal Medicine, 2004 - 2005
Johns Hopkins University School of MedicineClass of 2004

PubMed

DNA Methylation Classes of Stage II and III Primary Melanomas and Their Clinical and Prognostic Significance.
Kathleen Conway, Sharon N Edmiston, Amanda Vondras, Allison Reiner, David L Corcoran
JCO Precision Oncology. 2024-11-01
5 citations
InterMEL: An international biorepository and clinical database to uncover predictors of survival in early-stage melanoma.
Irene Orlow, Keimya D Sadeghi, Sharon N Edmiston, Jessica M Kenney, Cecilia Lezcano
Plos One. 2023-01-01
10 citations
Landscape of mutations in early stage primary cutaneous melanoma: An InterMEL study.
Li Luo, Ronglai Shen, Arshi Arora, Irene Orlow, Klaus J Busam
Pigment Cell & Melanoma Research. 2022-11-01

Journal Articles

Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell Transplants
Jeffrey F Scott, Konstantin V Grigoryan, Jeremy S Bordeaux, Meg R Gerstenblith, Julia S Lehman, JAMA Dermatology

Risk Factors for Keratinocyte Carcinoma in Recipients of Allogeneic Hematopoietic Cell TransplantsApril 2020